GDF-15: Diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme

J Cell Physiol. 2021 Aug;236(8):5564-5581. doi: 10.1002/jcp.30289. Epub 2021 Feb 12.

Abstract

Glioblastoma multiforme (GBM) is the commonest primary malignant brain tumor and has a remarkably weak prognosis. According to the aggressive form of GBM, understanding the accurate molecular mechanism associated with GBM pathogenesis is essential. Growth differentiation factor 15 (GDF-15) belongs to transforming growth factor-β superfamily with important roles to control biological processes. It affects cancer growth and progression, drug resistance, and metastasis. It also can promote stemness in many cancers, and also can stress reactions control, bone generation, hematopoietic growth, adipose tissue performance, and body growth, and contributes to cardiovascular disorders. The role GDF-15 to develop and progress cancer is complicated and remains unclear. GDF-15 possesses tumor suppressor properties, as well as an oncogenic effect. GDF-15 antitumorigenic and protumorigenic impacts on tumor development are linked to the cancer type and stage. However, the GDF-15 signaling and mechanism have not yet been completely identified because of no recognized cognate receptor.

Keywords: GBM; GDF-15; glioblastoma multiform; growth differentiation factor 15.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / pathology
  • Cell Proliferation / drug effects
  • Cell Proliferation / physiology
  • Glioblastoma / diagnosis
  • Glioblastoma / drug therapy*
  • Glioblastoma / pathology*
  • Growth Differentiation Factor 15 / drug effects
  • Growth Differentiation Factor 15 / metabolism*
  • Humans
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Transforming Growth Factor beta / metabolism

Substances

  • GDF15 protein, human
  • Growth Differentiation Factor 15
  • Transforming Growth Factor beta